Policy Expert Offers Suggestions for Curbing US Health Care Costs

14 hours ago
Chris@BMW

According to recent data, health expenditures in the U.S. reached $5.3 trillion in 2024. That figure equates to 18% of GDP, and…

Soligenix Inc. (NASDAQ: SNGX) Builds Momentum in Fight Against Rare, Chronic Cancer

1 day ago

Although CTCL may progress slowly in its early stages, it remains a chronic and ultimately progressive disease for many patients.…

Soligenix (NASDAQ: SNGX) Positioning for Impact in Growing Rare-Disease Landscape

5 days ago

The World Health Organization’s recent recognition of rare diseases as a global health priority underscores their collective impact. Soligenix remains…

New Compound Could Become a Transformational Brain Cancer Pill

5 days ago

Researchers at the University of Chicago have identified a compound that has shown efficacy in shrinking tumors in the brains of mice. This…

Circadian Regulation Could Boost Cancer Immunotherapy, New Study Finds

6 days ago

Scientists have found that keeping circadian rhythms, the variations in body processes during the course of the day, in mind…

The 47% Signal: Why Earth Science Tech Inc.’s (ETST) Management Is Betting the House on ETST

6 days ago

While many capitalization structures are diluted in the landscape of over-the-counter (“OTC”) markets, Earth Science Tech is doing the opposite,…

The US Formally Exits the World Health Organization

1 week ago

The United States has formally communicated its immediate withdrawal from the World Health Organization (WHO), denying the global body one of…

Meta Analysis Finds That Weight Reduction Reduces Severity of Psoriasis

2 weeks ago

Psoriasis is a chronic skin condition that afflicts at least 60 million individuals globally. Nearly 80% of these affected people also tend to be either overweight…

New Digital Twin Predicts Outcomes of Brain Cancer Treatments

2 weeks ago

Researchers at the University of Michigan (U-M) have developed a system that leverages both AI and machine learning to create a…

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy

2 weeks ago

LIXTE is developing a first-in-class therapy designed to enhance the effectiveness of existing cancer treatments Its lead compound, LB-100, targets…